Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease

Bone Marrow Transplant. 2002 Apr;29(8):709-10. doi: 10.1038/sj.bmt.1703550.

Abstract

A female patient with AML received an allogeneic BMT from her brother. She experienced two relapses managed with chemotherapy and donor leukocyte infusions. The patient subsequently developed extensive therapy-refractory chronic GVHD. Pseudoautologous blood stem cell transplantation was performed as a salvage treatment for chronic GVHD. Her blood stem cells were easily mobilized with cyclophosphamide and G-CSF. The conditioning regimen was well tolerated and consisted of 200 mg/kg cyclophosphamide and horse-derived antithymocyte globulin. A total of 4.03 x 10(6)/kg CD34+ cells were infused and hematological recovery was rapid. Chronic GVHD improved with the ability to taper steroids. Nine months post transplantation the patient died from leukemia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Autoimmune Diseases / etiology
  • Autoimmune Diseases / therapy
  • Chronic Disease
  • Fatal Outcome
  • Female
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / therapy*
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Transplantation, Autologous
  • Transplantation, Homologous